ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003

Politicians Applaud CPRIT’s New Direction; UT Gives Waiver To MD Anderson’s DePinho

October 26, 2012

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014

NABCO to close June 30.

January 30, 2004